Skip to content

Dog-Assisted Therapy in Dentistry

Dog-Assisted Therapy in Dental Care Settings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03324347
Enrollment
16
Registered
2017-10-27
Start date
2017-10-31
Completion date
2019-06-05
Last updated
2019-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Animal Assisted Therapy, Dental Anxiety, Pediatric Dentistry

Keywords

Animal-Assisted Intervention, Dog-Assisted Intervention, Dental Care, Questionnaire, Pilot Project, Dental Clinic

Brief summary

Dog-assisted therapy (DAT) is used in several contexts within various areas of health care. One documented effect is that the proximity of a dog may lower anxiety in perceived stressful situations. Many individuals are afraid to visit the dentist, and someone to the extent that they need medication or anesthesia in order to complete their dental treatment. Based on the literature and own empirical observations, the investigators believe that dog-assisted therapy in connection with dental care may have a positive effect on children with dental anxiety or children that avoid dental care. It is desirable to restrict the use of drugs for these patients because of associated risk and side effects. The purpose of this pilot study is to evaluate whether using a specially trained therapy dog can have a positive effect on children who are afraid in a dental care setting. Eligible participants (n=16) will meet twice at the dental clinic; one treatment session with a therapy dog in the dental clinic and one without. The therapy dog will be accompanied by a certified dog handler. The investigators will measure physiological variations before, during and after the treatment session. The guardian will complete validated questionnaires portraying the participant's experience of previous dental care. The participant and their guardian will also complete validated questionnaires describing their reactions from the two treatment sessions. A descriptive log for each session will be completed by the investigators.

Interventions

PROCEDURETherapydog

Presence of a therapydog during a clinical examination in a dental clinic

Sponsors

University of Tromso
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children who are afraid of visiting the dental office / children who avoid dental treatment, * Children who accept the presence of a dog, * Parents or guardians who accept the presence of a dog

Exclusion criteria

* Children or parent/guardian that are afraid of dogs, * Children or parent/guardian with known dog allergy, * Children who are immunocompromised, * Children who cannot understand or complete the patient-questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Examination achieved; Yes or Noup to 8 weeksWhether the child complied or not, so that a clinical oral examination could be accomplished within 30 minutes

Secondary

MeasureTime frameDescription
Child satisfactionup to 8 weeksThe child will describe his/her feelings by marking one of 6 different emoticon-style facial expressions where number 1 illustrate the most happy face and number 6 illustrates not happy at all.
Measurement of anxiety through the CFSS-DS scale (Dental subscale of Children's Fear Survey Schedule)up to 8 weeksThe parent/guardian will describe the child's dental fear on a five point scale where 1 is no fear and 5 is the worst fear.
Salivary cortisol levelup to 8 weeksMeasurement of cortisol from participant's saliva sample to assess if dog-assisted therapy (DAT) minimizes stress and anxiety
Heart rate variabilityup to 8 weeksHeart rate will be measured to assess if dog-assisted therapy (DAT) minimizes stress and anxiety. (Biopac Systems software)
Skin conductance (Electrodermal activity)up to 8 weeksSkin conductance will be measured to assess if dog-assisted therapy (DAT) minimizes stress and anxiety. (Biopac Systems software)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026